Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-alcoholic Fatty Liver Disease NAFLD”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT04850547
What this trial is testing

Effect of Fatty Liver Disease on Bone Density

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseOsteoporosis
Sohag University 80
Not applicableUnknownNCT03132662
What this trial is testing

Omega-3 vs Very Low Calorie Diet for Liver Size Reduction

Who this might be right for
Obesity, MorbidObesityNAFLD+1 more
McMaster University 60
Large-scale testing (Phase 3)Ended earlyNCT02704403
What this trial is testing

Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Nonalcoholic Steatohepatitis (NASH) With Fibrosis
Genfit 2,157
Testing effectiveness (Phase 2)WithdrawnNCT04761848
What this trial is testing

Evaluation the Safety and Efficacy of Cilostazol in Treatment of Patients With Fatty Liver Disease

Who this might be right for
Fatty Liver, Nonalcoholic
Sadat City University
Large-scale testing (Phase 3)Study completedNCT01245608
What this trial is testing

Prevention of Cardiovascular Disease Using a Single PolyPill in an Urban Population - Focus on Liver-Related Variables.

Who this might be right for
Cardiovascular Diseases
Tehran University of Medical Sciences 2,400
Testing effectiveness (Phase 2)Study completedNCT03375788
What this trial is testing

Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascular Risk

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseObesityObesity, Abdominal+2 more
Massachusetts General Hospital 51
Early research (Phase 1)Study completedNCT02612662
What this trial is testing

Assess the Safety and Tolerability of Single Doses of AZD4076 in Healthy Male Subjects

Who this might be right for
Non-alcoholic Steatohepatitis (NASH)
AstraZeneca 40
Post-approval studies (Phase 4)Study completedNCT01854463
What this trial is testing

The Effect of Vitamin D Supplementation in Type 2 Diabetes

Who this might be right for
DIABETES MELLITUS
Chuncheon Sacred Heart Hospital 158
Large-scale testing (Phase 3)Active Not RecruitingNCT04849728
What this trial is testing

Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 )

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Inventiva Pharma 1,000
Not applicableLooking for participantsNCT05842850
What this trial is testing

Non-alcoholic Fatty Liver Disease in Low Birth Weight Individuals

Who this might be right for
NAFLD
Steno Diabetes Center Copenhagen 8
Not applicableEnrolling By InvitationNCT07452744
What this trial is testing

Efficacy and Safety of Picroliv in Patients With Non-Alcoholic Fatty Liver Disease

Who this might be right for
Non Alcholic Fatty Liver Disease
Bioagile Therapeutics Pvt. Ltd. 170
Not applicableStudy completedNCT06031532
What this trial is testing

Effect of Vitamin A and Calcium in Patients With Non-alcoholic Fatty Liver Disease

Who this might be right for
Effect of Vitamin A and Calcium in Patients With Non-alcoholic Fatty Liver Patients
Sohag University 110
Testing effectiveness (Phase 2)Study completedNCT04521114
What this trial is testing

Leronlimab (PRO 140) in Patients With Nonalcoholic Steatohepatitis

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)
CytoDyn, Inc. 87
Testing effectiveness (Phase 2)Study completedNCT03042767
What this trial is testing

Anti-LPS Antibody Treatment for Pediatric NAFLD

Who this might be right for
Nonalcoholic Fatty Liver Disease (NAFLD)
Miriam Vos, MD 40
Not applicableUnknownNCT02124577
What this trial is testing

Development of Kinetic Biomarkers of Liver Fibrosis Measuring NAFLD

Who this might be right for
Non-alcoholic Fatty Liver Disease
University of California, San Diego 50
Not applicableStudy completedNCT05419765
What this trial is testing

Lysosomal Acid Lipase Activity in Nonalcoholic Fatty Liver Disease

Who this might be right for
Non-Alcoholic Fatty Liver Disease
University of Roma La Sapienza 316
Not applicableStudy completedNCT02148471
What this trial is testing

Fatty Acids, Genes and Microbiota in Fatty Liver

Who this might be right for
Nonalcoholic Fatty Liver DiseaseSteatosisNonalcoholic Steatohepatitis
Johane Allard 205
Not applicableStudy completedNCT03211299
What this trial is testing

Determinants of Liver Fat Composition

Who this might be right for
Fatty Liver, NonalcoholicInsulin Sensitivity
Maastricht University Medical Center 19
Testing effectiveness (Phase 2)Looking for participantsNCT05648214
What this trial is testing

A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Who this might be right for
Healthy VolunteersMetabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Regeneron Pharmaceuticals 172
Not applicableUnknownNCT03156881
What this trial is testing

Global Osteopathic Treatment for Patients With NAFLD

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Jenna Wilcox 48
Next Page